Page last updated: 2024-11-05

tranexamic acid and Glioma

tranexamic acid has been researched along with Glioma in 2 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wu, S1
Cao, Y1
Li, X1
Liu, Q1
Ye, Y1
Liu, X1
Zeng, L1
Tian, M1
Zänker, KS1
Stavrou, D1
Blümel, G1

Other Studies

2 other studies available for tranexamic acid and Glioma

ArticleYear
Attention-guided multi-scale context aggregation network for multi-modal brain glioma segmentation.
    Medical physics, 2023, Volume: 50, Issue:12

    Topics: Body Weight; Brain; Brain Neoplasms; Glioma; Humans; Image Processing, Computer-Assisted; Tranexamic

2023
Fibrin degradation products, produced by glioma cell-associated fibrinolysis and the partial inhibition of cell growth and migration in tissue culture.
    Cellular and molecular biology, including cyto-enzymology, 1979, Volume: 25, Issue:6

    Topics: Animals; Brain Neoplasms; Cell Division; Cell Migration Inhibition; Culture Techniques; Fibrin Fibri

1979